Alibaba
BABA
Tesla
TSLA
Netflix
NFLX
4
Broadcom
AVGO
5
NVIDIA
NVDA
US Stock MarketDetailed Quotes
CNSP CNS Pharmaceuticals
- 2.5000
- -0.1000-3.85%
Close Mar 11 16:00 ET
- 2.5000
- 0.00000.00%
Post 18:57 ET
3.75MMarket Cap0.00P/E (TTM)
2.6000High2.3820Low103.96KVolume2.5800Open2.6000Pre Close257.25KTurnover7.04%Turnover Ratio0.00P/E (Static)1.50MShares1100.000052wk High1.12P/B3.69MFloat Cap2.000052wk Low--Dividend TTM1.48MShs Float426742.5000Historical High--Div YieldTTM8.39%Amplitude2.0000Historical Low2.4740Avg Price1Lot Size
CNS Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 24.15%5.63M | -37.20%2.53M | -28.05%3.54M | 23.57%18.87M | 4.77%5.38M | 32.61%4.53M | 12.93%4.03M | 56.44%4.93M | 5.39%15.27M | 57.91%5.13M |
| Selling and administrative expenses | 23.20%1.38M | 19.64%1.41M | -17.98%1.11M | -20.07%4.77M | -48.54%1.11M | -7.25%1.12M | -12.15%1.18M | 7.80%1.36M | 27.48%5.97M | 140.15%2.15M |
| -General and administrative expense | 23.20%1.38M | 19.64%1.41M | -17.98%1.11M | -20.07%4.77M | -48.54%1.11M | -7.25%1.12M | -12.15%1.18M | 7.80%1.36M | 27.48%5.97M | 140.15%2.15M |
| Research and development costs | 24.47%4.24M | -60.76%1.12M | -31.88%2.43M | 51.56%14.1M | 43.25%4.27M | 54.47%3.41M | 28.10%2.85M | 88.89%3.57M | -5.15%9.3M | 26.61%2.98M |
| Operating profit | -24.15%-5.63M | 37.20%-2.53M | 28.05%-3.54M | -23.57%-18.87M | -4.77%-5.38M | -32.61%-4.53M | -12.93%-4.03M | -56.44%-4.93M | -5.39%-15.27M | -57.91%-5.13M |
| Net non-operating interest income expense | 107.99%22.97K | -163.05%-2.62K | 101.95%106 | 297.55%13.88K | 278.24%4.12K | 2,152.97%11.05K | 357.73%4.15K | -111.85%-5.44K | 24.32%-7.03K | -3.31%-2.31K |
| Non-operating interest income | 95.84%25.23K | -76.35%1.85K | --6.73K | --27.69K | --7K | --12.88K | --7.8K | --0 | --0 | --0 |
| Non-operating interest expense | 22.85%2.26K | 22.27%4.46K | 21.87%6.63K | 96.46%13.81K | 24.61%2.88K | 241.64%1.84K | 126.57%3.65K | 111.85%5.44K | -24.32%7.03K | 3.31%2.31K |
| Other net income (expense) | ||||||||||
| Income before tax | -23.95%-5.61M | 37.07%-2.53M | 28.13%-3.54M | -23.42%-18.85M | -4.64%-5.38M | -32.26%-4.52M | -12.77%-4.02M | -56.48%-4.93M | -5.37%-15.27M | -57.87%-5.14M |
| Income tax | ||||||||||
| Net income | -23.95%-5.61M | 37.07%-2.53M | 28.13%-3.54M | -23.42%-18.85M | -4.64%-5.38M | -32.26%-4.52M | -12.77%-4.02M | -56.48%-4.93M | -5.37%-15.27M | -57.87%-5.14M |
| Net income continuous Operations | -23.95%-5.61M | 37.07%-2.53M | 28.13%-3.54M | -23.42%-18.85M | -4.64%-5.38M | -32.26%-4.52M | -12.77%-4.02M | -56.48%-4.93M | -5.37%-15.27M | -57.87%-5.14M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -23.95%-5.61M | 37.07%-2.53M | 28.13%-3.54M | -23.42%-18.85M | -4.64%-5.38M | -32.26%-4.52M | -12.77%-4.02M | -56.48%-4.93M | -5.37%-15.27M | -57.87%-5.14M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -23.95%-5.61M | 37.07%-2.53M | 28.13%-3.54M | -23.42%-18.85M | -4.64%-5.38M | -32.26%-4.52M | -12.77%-4.02M | -56.48%-4.93M | -5.37%-15.27M | -57.87%-5.14M |
| Basic earnings per share | 99.54%-12.5 | 87.04%-336 | 81.50%-1.03K | 67.92%-7.59K | 72.80%-2.16K | 57.81%-2.71K | 61.24%-2.59K | 6.29%-5.54K | 39.32%-23.64K | 9.09%-7.95K |
| Diluted earnings per share | 99.54%-12.5 | 87.04%-336 | 81.50%-1.03K | 67.92%-7.59K | 72.80%-2.16K | 57.81%-2.71K | 61.24%-2.59K | 6.29%-5.54K | 39.32%-23.64K | 9.09%-7.95K |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!